Enhancement of the effect of low-dose cy
β
Alkwin Wanders; Gunnar Tufveson; Bengt Gerdin
π
Article
π
1992
π
Springer
π
English
β 447 KB
Sulphasalazine (SASP) is an immunomodulatory compound with disease-modifying activity in ulcerative colitis and in other autoimmune disorders. SASP was previously shown to prolong the survival of heart allografts in rats treated with cyclosporin A (CyA) for 9 days after transplantation. We have now